ANTISENSE THERAPEUTICS LIMITED has not announced any current capital raises, but we are collecting interest for future raises.
1. Create Account
Complete your onboarding digitally in less than 3 minutes.
2. View Terms
View the full term sheet for the capital raise.
3. Bid for Allocation
Submit and track your bid online.
10 March 2019
Antisense Therapeutics Limited (ANP.ASX) is an Australian publicly traded biopharmaceutical drug discovery and development company whose mission is to create, develop and commercialize novel antisense therapeutics for a variety of drug candidates including Duchenne Muscular Dystrophy (DMD), Multiple Sclerosis (MS), and Acromegaly.
6 Wallace Ave, Toorak VIC 3142, Australia
Fresh Equities does not have ANTISENSE THERAPEUTICS LIMITED directors data.
Fresh Equities does not have ANTISENSE THERAPEUTICS LIMITED news data.